EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Keratin-1 Predicts Recurrence and Treatment Response in Advanced Laryngeal Cancer: A Potential Therapeutic Target

Eun Kyung Jung, S M Abdus Salam iD, Hye-Bin Jang, Joo Yeon Koo iD, Eshrat Jahan iD, Sun-Ae Kim, Ji Young Lee iD, Kyung-Hwa Lee iD, Tae Mi Yoon

Current Oncology · 17.09.2025 · 32 (9) · 520

DOI: 10.3390/curroncol32090520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.09.2025. Verfasst von Eun Kyung Jung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School and Hwasun Hospital, Gwangju 58128, Republic of Korea. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Neoplasm Recurrence, Local, Biomarkers, Tumor, Keratin-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The survival rate of patients with advanced laryngeal cancer has not substantially improved over time. RNA sequencing analysis identified Keratin-1 (KRT1) as a gene potentially associated with cancer recurrence. This study investigated the association between KRT1 expression and recurrence in advanced laryngeal cancer. RNA sequencing was performed to identify candidate genes associated with recurrence. The effects of KRT1 expression on clinical outcomes were evaluated in patients with laryngeal cancer. Multiple experimental techniques were utilized. RNA sequencing of patient samples demonstrated higher KRT1 gene expression in the recurrence group than in non-recurrent cases. Patients with KRT1-positive immunostaining exhibited trends of worse overall survival (OS) and recurrence-free survival (RFS). In vitro studies showed that KRT1 knockdown suppressed tumor cell invasion, cell migration, and expression of epithelial–mesenchymal transition (EMT)-related genes in human head and neck squamous cell carcinoma (HNSCC) cell lines. KRT1 knockdown enhanced tumor cell apoptosis and exhibited synergistic effects with conventional radiation and chemotherapy treatments. KRT1 may serve as a biomarker for predicting advanced laryngeal cancer recurrence and assist with selecting patients to receive concurrent chemoradiotherapy (CCRT). Further molecular investigations are warranted to determine its effects, but KRT1 has potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsNeoplasm Recurrence, LocalBiomarkers, TumorKeratin-1Squamous Cell Carcinoma of Head and NeckSurvival RateChemoradiotherapyDisease-Free SurvivalPrognosisSequence Analysis, RNAGene Expression Regulation, NeoplasticGene Knockdown TechniquesEpithelial-Mesenchymal TransitionCell Line, TumorHumansRetrospective StudiesNeoplasm StagingMaleFemaleAdultMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

keratin-1laryngeal cancermolecular targeted therapyradioresistancerecurrence

Substanzen

KRT1 protein, humanBiomarkers, TumorKeratin-1

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School and Hwasun Hospital, Gwangju 58128, Republic of Korea.
  • Department of Pathology, Chonnam National University Medical School and Hwasun Hospital, Gwangju 58128, Republic of Korea.
  • Department of Biomedical Sciences, Chonnam National University Medical School and Hwasun Hospital, Gwangju 58128, Republic of Korea.
  • Department of BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Hwasun Hospital and Medical School, Gwangju 58128, Republic of Korea.

ORCID-Profile: S M Abdus Salam, Joo Yeon Koo, Eshrat Jahan, Ji Young Lee, Kyung-Hwa Lee

Förderung

  • National Research Foundation of Korea
  • Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (MSIT)

Zitieren

APA

Jung, E. K., Salam, S. M. A., Jang, H. B., Koo, J. Y., Jahan, E., Kim, S. A., Lee, J. Y., Lee, K. H., & Yoon, T. M. (2025). Expression of Keratin-1 Predicts Recurrence and Treatment Response in Advanced Laryngeal Cancer: A Potential Therapeutic Target. Current Oncology, 32(9), 520. https://doi.org/10.3390/curroncol32090520

Vancouver

Jung EK, Salam SMA, Jang HB, Koo JY, Jahan E, Kim SA, et al. Expression of Keratin-1 Predicts Recurrence and Treatment Response in Advanced Laryngeal Cancer: A Potential Therapeutic Target. Current Oncology. 2025;32(9):520. doi:10.3390/curroncol32090520

BibTeX
@article{Jung2025,
  author = {Jung, Eun Kyung and Salam, S M Abdus and Jang, Hye-Bin and Koo, Joo Yeon and Jahan, Eshrat and Kim, Sun-Ae and Lee, Ji Young and Lee, Kyung-Hwa and Yoon, Tae Mi},
  title = {Expression of Keratin-1 Predicts Recurrence and Treatment Response in Advanced Laryngeal Cancer: A Potential Therapeutic Target},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {9},
  pages = {520},
  doi = {10.3390/curroncol32090520}
}
Kostenlos starten →